MS Validated Antibodies offers:

Only excellent antibodies validated in more than a thousand tissues

Only one antibody per target, which performs at least as well as its “best in class” competitor

Unique documentation of antibody performance

CPA1 (clone MSVA-601M) is a new marker for immunohistochemistry with very high sensitivity and specificity (>99%) for acinar cell carcinoma of the pancreas. A study on 15,680 tumors of >100 different tumor entities will appear in the next edition of the American Journal of Surgical Pathology.

Acinar cell carcinoma of the pancreas makes up for only 1-2% of pancreatic tumors but is misdiagnosed in a considerable fraction of cases. Based on the data by Uhlig et al, the use of MSVA-601M results in a considerably safer distinction of this tumor entity.

The paper was just published in the American Journal of Surgical Pathology.

Uhlig R et al. Carboxypeptidase A1 (CPA1) Immunohistochemistry Is Highly Sensitive and Specific for Acinar Cell Carcinoma (ACC) of the Pancreas. Am J Surg Pathol. 2022 Jan 1;46(1):97-104.

MSVA Catalog 2022 is available to download now.

MSVA Catalog 2022